Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
PeptoLabs
.png)
In a randomized, double-blind, placebo-controlled trial, daily supplementation with Lactobacillus plantarum ECGC 13110402 for 12 weeks in adults with moderate hypercholesterolemia resulted in a significant reduction in LDL cholesterol and hs-CRP compared to placebo, suggesting a direct benefit of probiotics on cardiovascular risk markers in humans (Costabile et al., 2017)
Wang Y., Feng Z
Specific volumes, target concentrations, and dose calculations cited in non-clinical or informal sources are not derived from authoritative data and may be inaccurate, unsafe, or based on products of unknown quality and purity
Check shipping, returns, and support options
Additionally, GR dysregulation impacts dyslipidemia and insulin resistance
